One of the anti-abortion doctors suing the U.S. Food and Drug Administration over its approval of medication abortion is currently consulting with a company about developing a breast cancer treatment using the same drug, mifepristone.
This is the latest attempt by a family doctor to move beyond his medical qualifications and into medical consulting.
Dr. George Delgado, the company behind Res Nova Biologics, which is developing a breast cancer treatment using mifepristone, despite plaintiffs’ claims in the lawsuit that federal approval was illegally rushed. will be joining the Scientific Advisory Board of 4 year process) and argued that the drug’s approved use for first-trimester abortions should be revoked.
but, press release When announcing his role at Res Nova, he said: “In my opinion, the concept of harnessing the effects of abortifacients for life-saving rather than life-saving scenarios is very exciting. I am proud to join this expert treatment development team.”
Delgado is among them. 4 anti-abortion doctors and the claims of four conservative Christian medical organizations. is mainly based on About anecdotes and research raised a red flag.and they are contradictory overwhelming evidence Mifepristone remains safe after 5.6 million uses and has been shown to be effective in early pregnancy abortion, miscarriage management, and other medical conditions.of american medical association criticized the conservative court that proceeded with the case as “high-minded.”[ing] Speculative pseudoscience surrounding data and evidence is rampant and arbitrarily rolls back access to safe and effective medicines, leaving millions of women without essential reproductive health care. I have to. ”
Nevertheless, the fate of abortion access in the United States is once again at stake. Future decisions The U.S. Supreme Court has been asked to either take up the case or effectively reinstate old restrictions on the drug. The lower court’s conservative judges relied on the plaintiffs’ argument that mifepristone is FDA-approved for abortions, as well as testimony from Delgado and other doctors who allege personal injury claims.
in legal declaration In a report filed in November 2022, Delgado wrote that he had treated women “suffering from complications from chemical abortions,” but cited only examples of women who he said had felt remorse or emotional distress. Ta. Delgado cited her candidacy as a reason for her candidacy: She also said patients would lose money if they had a medical abortion at a family clinic in Escondido, Calif., instead of using prenatal care services. also offers Anti-abortion counseling and a controversial protocol that claims to reverse the effects of mifepristone. The American College of Obstetricians and Gynecologists states that this protocol isnot supported by science”
“[T]”Losing the opportunity to provide specialized prenatal care to mothers and care for unborn babies is a tangible financial loss to my practice,” he wrote.
Delgado is an outspoken anti-abortion activist best known for his so-called “abortion pill reversal.” This drug is not regulated by the FDA; unverified claims led AMA goes to court A lawsuit was filed in North Dakota in 2019 over a state law promoting this process. Delgado serves as a member of the American Association of Pro-Life Obstetricians and Gynecologists. board of directors, even though I’m not an obstetrician-gynecologist.Delgado also testified as a medical expert during the height of the COVID-19 pandemic To keep megachurches openHowever, he is not a public health expert or epidemiologist. In his legal filings, he claimed his expertise from having “treated many people with infectious diseases, including viral diseases such as influenza, which are more likely to occur during epidemics.”
The doctor has now been hired to serve on the scientific advisory board of a Chula Vista, Calif.-based biotechnology company developing a breast cancer treatment using mifepristone.
Res Nova, a breast cancer-focused spin-off of Therapeutic Solutions International, Inc., has announced that it is developing “RU-486 and Ptero, which have been shown to overcome tumor-associated immunosuppression and increase responsiveness to chemotherapy and immunotherapy. We are developing FloraStilbene, a unique combination of stilbenes. ” by press release (The company calls mifepristone RU-486, a name given to the drug during clinical testing.) ”, we have a contract with a dispensing pharmacy.
“The similarities between pregnancy and oncology are striking, including angiogenesis, immunomodulation, and rapid growth,” Delgado says.
Delgado is board certified in family medicine, hospice and palliative medicine. The American Board of Family Medicine does not specialize in oncology or immunology. Res Nova advisory board members Currently posted on the website (Delgado not yet added) includes members with a variety of specialties, including board-certified neurologists and neuro-oncologists, pharmacists, lawyers, technology executives, and IT consultants.
Famela Ramos, president and CEO of Les Nova, is a nurse but not a successful person. Candidates for Congress and Board of Educationand a board member of the Anti-Abortion Pregnancy Center in Chula Vista, said she recruited Delgado to be part of the so-called abortion reversal technology that Delgado has been developing and promoting for more than a decade.
“Having known for many years of Dr. Delgado’s work and his great success in protecting both mothers and babies, I am grateful to him for this unique intersection of reproductive medicine, immunology, reproductive medicine, immunology, and reproductive medicine. I’m excited to have the opportunity to leverage Delgado’s scientific and medical expertise,” Ramos said in a statement, calling Delgado an “expert in the biology of pregnancy and abortion drugs,” and There was no mention of the lawsuit against Princeton.
Delgado also suggests that: Abortion is linked to breast cancer, a common anti-abortion argument.but According to the American Cancer Society“Scientific research studies have not found a causal relationship between abortion and breast cancer.”
Ramos and Delgado declined to answer questions from State Newsroom.
Major U.S. medical groups say Delagado’s lawsuit could have long-term effects unrelated to abortion. Turning pharmaceutical research and development upside down. Mifepristone is currently investigated in clinical trials We treat various cancers and mental illnesses. The lawsuit targets mifepristone and the drug’s manufacturers for its specific use in abortion. Said The restrictions on medication abortion regimens do not apply to clinical trials investigating mifepristone for uses other than abortion. However, researchers Reported Even before Roe v. Wade was overturned, anti-abortion policies made research into mifepristone difficult.
Mifepristone may already be difficult to obtain for people seeking abortions, but due to high demand and confusion over medical abortion laws, the drug is now no longer indicated for miscarriage management, according to a State Newsroom affiliate. It is said that it is difficult to obtain even for external use. state line.
“Dr. Delgado’s research interest in mifepristone as a potential preventive agent for cancer demonstrates the important medical value that mifepristone provides,” American Obstetricians and Gynecology wrote in an amicus brief. said Molly Megan, chief legal officer and general counsel for the scientific society. Defending mifepristone’s approval and safety record in FDA litigation.
Delgado has identified a network of anti-abortion health care providers willing to implement so-called abortion pill reversal treatments without much data to back them up and based on the training of doctors at abortion-instructing institutes. contributed to the construction of Catholic friendly approach Towards reproductive health. It is currently managed by Heartbeat International, a network of anti-abortion pregnancy centers. Abortion Pill Rescue Network.
The FDA’s current medical abortion plan, recommended up to 10 weeks of pregnancy, uses mifepristone, which blocks the hormone progesterone, followed by misoprostol, a drug that induces labor. In a “reversal” protocol, the patient discontinues her second drug in the regimen and receives progesterone.state newsroom I had an interview A patient continued her pregnancy and delivered a healthy baby after receiving this treatment at an anti-abortion pregnancy center in Idaho. However, medical groups such as ACOG and the AMA say there is not enough evidence to show that it is progesterone that causes a pregnancy to continue, and that it is progesterone that prevents an abortion from being completed.One attempt at a controlled study of this protocol Finished in the middle The obstetrician-gynecologist and mifepristone expert who led the study deemed mifepristone unsafe after three patients experienced bleeding.
Several states have passed laws requiring abortion clinics to inform patients that they may cancel the abortion if they change their mind, and some states now do not promote or promote this treatment. It’s holding marketing back.
California Attorney General Sue Heartbeat International Another California-based Emergency Pregnancy Network has widely promoted its “abortion pill reversal” despite unproven claims under the state’s false advertising and unfair competition laws.
Colorado became the first state to ban the procedure earlier this year, followed by a lawsuit from Catholic clinics.state regulators ruled So-called “abortion reversal treatment” is not a recognized medical practice.But last weekend, a federal judge appointed by former President Donald Trump blocked a new state lawcited the plaintiffs’ freedom of religion.
Get the morning headlines delivered to your inbox
